p53 Expression as a Prognostic Indicator of 5-Year Survival in Endometrial Cancer
- 1 September 1999
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 74 (3) , 468-471
- https://doi.org/10.1006/gyno.1999.5482
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Global cancer statisticsCA: A Cancer Journal for Clinicians, 1999
- Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbb-2) and p53 in proliferative, hyperplastic, and malignant endometriumHuman Pathology, 1998
- Prognostic significance of p53, bcl-2, vimentin, and S 100 protein-positive langerhans cells in endometrial carcinomaHuman Pathology, 1998
- p53 overexpression in advanced-stage endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1996
- Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomasHuman Pathology, 1996
- p53 as a Prognostic Indicator in Endometrial CancerGynecologic Oncology, 1996
- Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survivalHuman Pathology, 1994
- The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesisBritish Journal of Cancer, 1994
- ImmunohistochemistryPublished by Springer Nature ,1994